Cargando…

Conventional and Pro-Inflammatory Pathways of Fibrinolytic Activation in Non-Traumatic Hyperfibrinolysis

Hyperfibrinolysis (HF) frequently occurs after severe systemic hypoperfusion during major trauma and out-of-hospital cardiac arrest (OHCA). In trauma-induced HF, hypoperfusion, the activation of protein C (APC), and the release of tissue plasminogen activator (t-PA) have been identified as the drivi...

Descripción completa

Detalles Bibliográficos
Autores principales: Zipperle, Johannes, Ziegler, Bernhard, Schöchl, Herbert, Voelckel, Wolfgang, Dungel, Peter, Cadamuro, Janne, Osuchowski, Marcin, Schlimp, Christoph J., Oberladstätter, Daniel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9787796/
https://www.ncbi.nlm.nih.gov/pubmed/36555922
http://dx.doi.org/10.3390/jcm11247305
_version_ 1784858598947422208
author Zipperle, Johannes
Ziegler, Bernhard
Schöchl, Herbert
Voelckel, Wolfgang
Dungel, Peter
Cadamuro, Janne
Osuchowski, Marcin
Schlimp, Christoph J.
Oberladstätter, Daniel
author_facet Zipperle, Johannes
Ziegler, Bernhard
Schöchl, Herbert
Voelckel, Wolfgang
Dungel, Peter
Cadamuro, Janne
Osuchowski, Marcin
Schlimp, Christoph J.
Oberladstätter, Daniel
author_sort Zipperle, Johannes
collection PubMed
description Hyperfibrinolysis (HF) frequently occurs after severe systemic hypoperfusion during major trauma and out-of-hospital cardiac arrest (OHCA). In trauma-induced HF, hypoperfusion, the activation of protein C (APC), and the release of tissue plasminogen activator (t-PA) have been identified as the driving elements of premature clot breakdown. The APC pathway also plays a role in inflammatory responses such as neutrophil extracellular trap formation (NETosis), which might contribute to lysis through cleavage of fibrin by neutrophil elastases. We investigated whether the APC and the plasminogen pathway were general drivers of HF, even in the absence of a traumatic incident. Additionally, we were interested in inflammatory activation such as the presence of NETs as potential contributing factors to HF. A total of 41 patients with OHCA were assigned to a HF and a non-HF group based on maximum lysis (ML) in thromboelastometry. Thrombin–antithrombin (TAT)-complex, soluble thrombomodulin (sTM), APC–PC inhibitor complex, t-PA, PAI-1, t-PA–PAI-1 complex, plasmin–antiplasmin (PAP), d-dimers, neutrophil elastase, histonylated DNA (hDNA) fragments, and interleukin-6 were assessed via immunoassays in the HF group vs. non-HF. APC–PC inhibitor complex is significantly higher in HF patients. Antigen levels of t-PA and PAI-1 do not differ between groups. However, t-PA activity is significantly higher and t-PA–PAI-1 complex significantly lower in the HF group. Consistent with these results, PAP and d-dimers are significantly elevated in HF. HDNA fragments and neutrophil elastase are not elevated in HF patients, but show a high level of correlation, suggesting NETosis occurs in OHCA as part of inflammatory activation and cellular decay. Just as in trauma, hypoperfusion, the activation of protein C, and the initiation of the plasminogen pathway of fibrinolysis manifest themselves in the HF of cardiac arrest. Despite features of NETosis being detectable in OHCA patients, early pro-inflammatory responses do not appear be associated with HF in cardiac arrest.
format Online
Article
Text
id pubmed-9787796
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-97877962022-12-24 Conventional and Pro-Inflammatory Pathways of Fibrinolytic Activation in Non-Traumatic Hyperfibrinolysis Zipperle, Johannes Ziegler, Bernhard Schöchl, Herbert Voelckel, Wolfgang Dungel, Peter Cadamuro, Janne Osuchowski, Marcin Schlimp, Christoph J. Oberladstätter, Daniel J Clin Med Article Hyperfibrinolysis (HF) frequently occurs after severe systemic hypoperfusion during major trauma and out-of-hospital cardiac arrest (OHCA). In trauma-induced HF, hypoperfusion, the activation of protein C (APC), and the release of tissue plasminogen activator (t-PA) have been identified as the driving elements of premature clot breakdown. The APC pathway also plays a role in inflammatory responses such as neutrophil extracellular trap formation (NETosis), which might contribute to lysis through cleavage of fibrin by neutrophil elastases. We investigated whether the APC and the plasminogen pathway were general drivers of HF, even in the absence of a traumatic incident. Additionally, we were interested in inflammatory activation such as the presence of NETs as potential contributing factors to HF. A total of 41 patients with OHCA were assigned to a HF and a non-HF group based on maximum lysis (ML) in thromboelastometry. Thrombin–antithrombin (TAT)-complex, soluble thrombomodulin (sTM), APC–PC inhibitor complex, t-PA, PAI-1, t-PA–PAI-1 complex, plasmin–antiplasmin (PAP), d-dimers, neutrophil elastase, histonylated DNA (hDNA) fragments, and interleukin-6 were assessed via immunoassays in the HF group vs. non-HF. APC–PC inhibitor complex is significantly higher in HF patients. Antigen levels of t-PA and PAI-1 do not differ between groups. However, t-PA activity is significantly higher and t-PA–PAI-1 complex significantly lower in the HF group. Consistent with these results, PAP and d-dimers are significantly elevated in HF. HDNA fragments and neutrophil elastase are not elevated in HF patients, but show a high level of correlation, suggesting NETosis occurs in OHCA as part of inflammatory activation and cellular decay. Just as in trauma, hypoperfusion, the activation of protein C, and the initiation of the plasminogen pathway of fibrinolysis manifest themselves in the HF of cardiac arrest. Despite features of NETosis being detectable in OHCA patients, early pro-inflammatory responses do not appear be associated with HF in cardiac arrest. MDPI 2022-12-09 /pmc/articles/PMC9787796/ /pubmed/36555922 http://dx.doi.org/10.3390/jcm11247305 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Zipperle, Johannes
Ziegler, Bernhard
Schöchl, Herbert
Voelckel, Wolfgang
Dungel, Peter
Cadamuro, Janne
Osuchowski, Marcin
Schlimp, Christoph J.
Oberladstätter, Daniel
Conventional and Pro-Inflammatory Pathways of Fibrinolytic Activation in Non-Traumatic Hyperfibrinolysis
title Conventional and Pro-Inflammatory Pathways of Fibrinolytic Activation in Non-Traumatic Hyperfibrinolysis
title_full Conventional and Pro-Inflammatory Pathways of Fibrinolytic Activation in Non-Traumatic Hyperfibrinolysis
title_fullStr Conventional and Pro-Inflammatory Pathways of Fibrinolytic Activation in Non-Traumatic Hyperfibrinolysis
title_full_unstemmed Conventional and Pro-Inflammatory Pathways of Fibrinolytic Activation in Non-Traumatic Hyperfibrinolysis
title_short Conventional and Pro-Inflammatory Pathways of Fibrinolytic Activation in Non-Traumatic Hyperfibrinolysis
title_sort conventional and pro-inflammatory pathways of fibrinolytic activation in non-traumatic hyperfibrinolysis
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9787796/
https://www.ncbi.nlm.nih.gov/pubmed/36555922
http://dx.doi.org/10.3390/jcm11247305
work_keys_str_mv AT zipperlejohannes conventionalandproinflammatorypathwaysoffibrinolyticactivationinnontraumatichyperfibrinolysis
AT zieglerbernhard conventionalandproinflammatorypathwaysoffibrinolyticactivationinnontraumatichyperfibrinolysis
AT schochlherbert conventionalandproinflammatorypathwaysoffibrinolyticactivationinnontraumatichyperfibrinolysis
AT voelckelwolfgang conventionalandproinflammatorypathwaysoffibrinolyticactivationinnontraumatichyperfibrinolysis
AT dungelpeter conventionalandproinflammatorypathwaysoffibrinolyticactivationinnontraumatichyperfibrinolysis
AT cadamurojanne conventionalandproinflammatorypathwaysoffibrinolyticactivationinnontraumatichyperfibrinolysis
AT osuchowskimarcin conventionalandproinflammatorypathwaysoffibrinolyticactivationinnontraumatichyperfibrinolysis
AT schlimpchristophj conventionalandproinflammatorypathwaysoffibrinolyticactivationinnontraumatichyperfibrinolysis
AT oberladstatterdaniel conventionalandproinflammatorypathwaysoffibrinolyticactivationinnontraumatichyperfibrinolysis